EVALUATION OF THE CLINICAL EFFECT OF SIMVASTATIN IN PATIENTS WITH UNSTABLE ANGINA AT A YOUNG AGE

Authors

  • Farida Odylovna Khasanjanova PhD. assistant of the chair of Internal Medicine no.
  • Pulatova Kristina Samveilovna. assistant professor of Internal medicine department
  • Yusupova Idrisahon Bakhtiyorovna 6th year student of the medical faculty Samarkand State Medical University

Keywords:

CHD, young age, atherosclerosis

Abstract

The clinical effect of rosuvostatin in patients with coronary heart disease (CHD) at young age was studied. We examined 120 patients with CHD aged 18 to 44 years (mean age 32.0±5.0 years). All patients underwent history taking, anthropometry, general clinical, laboratory, biochemical (lipid spectrum) and instrumental examinations. The obtained analysis of lipid profile in patients with IHD showed that simvastatin in the daily dose of 20 mg in 3 months showed hypolipidemic effect with good tolerability

Downloads

Published

2023-04-18

How to Cite

Farida Odylovna Khasanjanova, Pulatova Kristina Samveilovna., & Yusupova Idrisahon Bakhtiyorovna. (2023). EVALUATION OF THE CLINICAL EFFECT OF SIMVASTATIN IN PATIENTS WITH UNSTABLE ANGINA AT A YOUNG AGE. European Scholar Journal, 4(4), 116-118. Retrieved from https://scholarzest.com/index.php/esj/article/view/3462

Issue

Section

Articles